New York 9/12/2013 12:58:31 AM
News / Finance

Samsung Electronics Company Using Arrayit Corporation’s Proprietary SuperStreptavidin Microarray Substrate Slides

Listonstreetpulse.com announces that Suwon, South Korea-based electronics giant Samsung Electronics Company is using Arrayit Corporation’s (OTC: ARYC) proprietary SuperStreptavidin Microarray Substrate Slides to capture and analyze circulating breast cancer tumor cells. The groundbreaking research entitled, “Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles” was published by Samsung authors in the September issue of Biosensors and Bioelectronics. The research paper is available online at: http://www.sciencedirect.com/science/article/pii/S0956566313002108. 

With the help of Arrayit’s technology, researchers at Samsung are accelerating the identification of circulating tumor cells (CTCs). This may eventually lead to earlier diagnosis of metastatic breast cancer and other challenging illnesses. To date, Arrayit has manufactured over 1,000,000 Microarray Substrate Slides with aggregate sales of approximately $10 million. Samsung’s continuing research and potential commercialization could further drive the company’s consumable sales. 

To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/

About Arrayit Corporation                            
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.

About Liston Street Pulse                                                 
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.

###